Cubist Systematic Strategies’s GALENA BIOPHARMA INC COM RXII Stock Holding History

Cubist Systematic Strategies’s Portfolio RXII Stock Details RXII Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q4	–	Sell	-2,226	Closed	-$1K	–	2049
2016 Q3	$1K	Buy	+2,226	New	+$1K	﹤0.01%	1673

Cubist Systematic Strategies's RXII Position: Q4 2016 in Review

Cubist Systematic Strategies sold out of GALENA BIOPHARMA INC COM (RXII) in Q4 2016, closing a stake of 2,226 shares — an estimated $1K sold.

Cubist Systematic Strategies first reported a position in RXII in Q3 2016 and held it in 1 quarter. The position peaked at $1K in Q3 2016. 0 funds tracked by Wall St. Rank hold RXII as of Q4 2016.

Cubist Systematic Strategies reported no remaining GALENA BIOPHARMA INC COM position as of Q4 2016 after selling out during the quarter.
Cubist Systematic Strategies sold 2,226 GALENA BIOPHARMA INC COM shares in Q4 2016, an estimated $1K.
Cubist Systematic Strategies first reported a position in GALENA BIOPHARMA INC COM in Q3 2016 and held it in 1 quarter.
Cubist Systematic Strategies's GALENA BIOPHARMA INC COM position peaked at $1K in Q3 2016.
0 funds tracked by Wall St. Rank held GALENA BIOPHARMA INC COM as of Q4 2016.

Based on Cubist Systematic Strategies's 13F filing for Q4 2016, filed 14 Feb 2017.